During the past decade, Tilda Research conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tilda Research" #1 collaborator was "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tilda Research" are "Alzheimer Disease" (2 trials), "Articular Cartilage Defect" (1 trials), "Articular Cartilage Degeneration" (1 trials), "Early Alzheimer's Disease" (1 trials) and "Urinary Tract Infections" (1 trials). Many other conditions were trialed in "Tilda Research" in a lesser frequency.

Most popular intervention types in "Tilda Research" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Donanemab" (2 trials), "Autologous Chondrocyte Implantation (CartiLife®)" (1 trials), "Experimental: ALZ-801" (1 trials) and "LBP-EC01" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tilda Research" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Tilda Research". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Tilda Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tilda Research, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".